144 related articles for article (PubMed ID: 2077344)
1. Dissociation between Limulus neutralisation and in vivo protection in monoclonal antibodies directed against endotoxin core structures.
McConnell JS; Appelmelk BJ; Cohen J
Microb Pathog; 1990 Jul; 9(1):55-9. PubMed ID: 2077344
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
Mashimo J; Mizutani T; Mita A; Kasai N
Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
Nys M; Cloes JM; Demonty J; Joassin L
J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
[TBL] [Abstract][Full Text] [Related]
5. Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.
Greisman SE; Johnston CA
J Infect Dis; 1988 Jan; 157(1):54-64. PubMed ID: 2447200
[TBL] [Abstract][Full Text] [Related]
6. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipid A- and lipopolysaccharide-induced cytokine secretion, B cell mitogenesis, and lethal shock by lipid A-specific murine monoclonal antibodies.
Ramachandra RN; Berczi A; Sehon AH; Berczi I
J Infect Dis; 1993 May; 167(5):1151-9. PubMed ID: 8486948
[TBL] [Abstract][Full Text] [Related]
8. A comparison of specificity and biological activity of polyclonal and monoclonal antibodies raised against Salmonella minnesota R595 lipopolysaccharide.
Mehta ND; Wilson BM; Rapson NT; Easmon CS
J Med Microbiol; 1990 Feb; 31(2):85-93. PubMed ID: 2304067
[TBL] [Abstract][Full Text] [Related]
9. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.
Di Padova FE; Brade H; Barclay GR; Poxton IR; Liehl E; Schuetze E; Kocher HP; Ramsay G; Schreier MH; McClelland DB
Infect Immun; 1993 Sep; 61(9):3863-72. PubMed ID: 8359907
[TBL] [Abstract][Full Text] [Related]
10. Anti-endotoxin monoclonal antibodies protect by enhancing bacterial and endotoxin clearance.
Burd RS; Cody CS; Raymond CS; Dunn DL
Arch Surg; 1993 Feb; 128(2):145-50; discussion 150-1. PubMed ID: 7679267
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of neutralization of endotoxin by monoclonal antibodies to O and R determinants of lipopolysaccharide.
Sagawa T; Hitsumoto Y; Kanoh M; Utsumi S; Kimura S
Adv Exp Med Biol; 1990; 256():341-4. PubMed ID: 2183557
[No Abstract] [Full Text] [Related]
13. The expression of endotoxic activity in the Limulus test as compared to cytokine production in immune cells.
Brandenburg K; Howe J; Gutsman T; Garidel P
Curr Med Chem; 2009; 16(21):2653-60. PubMed ID: 19601802
[TBL] [Abstract][Full Text] [Related]
14. Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.
Ng AK; Chen CL; Chang CM; Nowotny A
J Gen Microbiol; 1976 May; 94(1):107-16. PubMed ID: 778329
[TBL] [Abstract][Full Text] [Related]
15. New microassay for quantitation of endotoxin using Limulus amebocyte lysate combined with enzyme-linked immunosorbent assay.
Zhang GH; Baek L; Koch C
J Clin Microbiol; 1988 Aug; 26(8):1464-70. PubMed ID: 3170710
[TBL] [Abstract][Full Text] [Related]
16. Immunological intervention in endotoxin shock.
Ziegler EJ
Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
[No Abstract] [Full Text] [Related]
17. Characterization of murine monoclonal antibodies to Escherichia coli J5.
Miner KM; Manyak CL; Williams E; Jackson J; Jewell M; Gammon MT; Ehrenfreund C; Hayes E; Callahan LT; Zweerink H
Infect Immun; 1986 Apr; 52(1):56-62. PubMed ID: 3514463
[TBL] [Abstract][Full Text] [Related]
18. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
Imbach P; Hässig A; Cottier H
Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
[No Abstract] [Full Text] [Related]
19. Analysis of the immune response to lipopolysaccharide. Existence of an interspecies cross-reactive idiotype associated with anti-lipid A antibodies.
Su SD; Ward MM; Apicella MA; Ward RE
J Immunol; 1990 Nov; 145(9):2994-3001. PubMed ID: 2212671
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide.
Priest BP; Brinson DN; Schroeder DA; Dunn DL
Surgery; 1989 Aug; 106(2):147-54; discussion 154-5. PubMed ID: 2763023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
